VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

OpenAI said that, beginning Tuesday, this new version of ChatGPT would be available to people using both the free and paid ...

Fandango has revealed its list of the 10 most anticipated 2025 summer movies, and while The Fantastic Four: First Steps has ...